Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction

NCT04729361 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT04729361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2021
Completion date
November 30, 2021
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disease, iugr, prenatal disorder